“Ofatumumab: A Second Generation Anti-CD20 Monoclonal Antibody in Chronic Lymphocytic Leukemia”. Hematology Meeting Reports 3, no. 3 (June 12, 2009). Accessed June 13, 2026. https://journals.pagepress.net/hmr/article/view/583.